996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

You are here: Industry Insights > EoE

News List

FDA Grants Dupixent Breakthrough Therapy Designation for Eosinophilic Esophagitis americanpharmaceuticalreview
September 18, 2020
Regeneron Pharmaceuticals and Sanofi announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Dupixent? (dupilumab) for the treatment of patients 12 years and older with eosinophilic esophagitis (EoE).
Dupixent Eosinophilic Esophagitis Trial Meets Both Co-Primary Endpoints americanpharmaceuticalreview
June 01, 2020
Regeneron Pharmaceuticals and Sanofi announced positive results from Part A of the pivotal Phase 3 trial evaluating Dupixent? (dupilumab) in patients 12 years and older with eosinophilic esophagitis (EoE).
Fasenra Granted Orphan Drug Designation americanpharmaceuticalreview
September 03, 2019
AstraZeneca announced the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE).